NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/19/2026
Back to search
Official data from USPTO
TURN CANCER AGAINST ITSELF
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
TURN CANCER AGAINST ITSELF
ST13
US500000098405995Class
5, 44
Filing
98405995
Registration
8264526
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
05/19/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 44
Filing date
02/14/2024
Registration date
05/19/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/19/2026
Last transaction
05/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/25/2025
First use in commerce
09/25/2025
Drawing code
4
Owner type
03
Owner location
Redwood City, CA, US
Examiner
CLYBURN, CARLA DIONNE
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Earli Inc.
Representatives
Ted D. Karr Berkeley Law & Technology Group LLP
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Products for the prevention of cancer in humanspharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in humanspharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the localization of cancer in humanspharmaceutical products to express a synthetic biomarker for localization of cancer; Products for the therapy of cancer in humanspharmaceutical products to express a treatment agent for treating cancer; Products for the prevention of cancer in animalspharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in animalspharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the therapy of cancer in animalspharmaceutical products to express a treatment agent for treating cancer
Class 44
Medical services for the prevention of cancer in humansmedical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in humansmedical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the localization of cancer in humansmedical assay processing provided by medical laboratories and medical analysis services for the localization of cancer; Medical services for the therapy of cancer in humansmedical assay processing provided by medical laboratories and medical analysis services for treating cancer; Medical services for the prevention of cancer in animalsmedical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in animalsmedical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the therapy of cancer in animalsmedical assay processing provided by medical laboratories and medical analysis services for the treatment of cancer
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/19/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/29/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/29/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/18/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/15/2026
IUAF
USE AMENDMENT FILED
11/13/2025
EISU
TEAS STATEMENT OF USE RECEIVED
11/13/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/15/2025
EX1G
SOU EXTENSION 1 GRANTED
06/02/2025
EXT1
SOU EXTENSION 1 FILED
06/02/2025
EEXT
SOU TEAS EXTENSION RECEIVED
06/02/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/22/2024
PUBO
PUBLISHED FOR OPPOSITION
10/22/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2024
DOCK
ASSIGNED TO EXAMINER
09/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/17/2024
NWAP
NEW APPLICATION ENTERED
02/14/2024
Continuous trademark protection
Get notified about every new filing that threatens TURN CANCER AGAINST ITSELF or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.